glp-1 and weight loss Learn from this Busy Mom's 71-lb Success with Half of GLP-1 users ditch

Tirzepatide Once Weekly for the Treatment of Obesity: Participants in this study complete a 60-week Weight-Loss Period on Tirzepatide, followed by a 52-week Weight Maintenance Period, where they are assigned to either Tirzepatide 5 mg, the maximum tolerated dose of Tirzepatide, and saw successful results

This is a big milestone for GLP-1s and for patient access more broadly

Reduced HGH levels are associated with: Increased visceral fat Reduced lean muscle mass Slower tissue repair Decreased sleep quality Lower metabolic efficiency This decline is part of normal aging but may be accelerated by chronic stress, poor sleep, and metabolic dysfunction

,